Ascites is a build up of fluid in the abdomen (tummy). It can be caused by some types of cancer. It can also be caused by other health conditions. Doctors can treat or control the ascites. But ...

New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...

When fluid accumulates in the abdominal cavity, it is called ascites. Cirrhosis of the liver is the most common cause of ascites but other conditions such as heart failure, kidney failure, infection ...

Ascites develops in cirrhosis from increased portal pressure within the liver, with transudation of fluid and proteins into the pace of Disse. When fluid accumulation exceeds the capacity of the ...

Challenges in developing drugs for pancreatic ductal adenocarcinoma (PDAC) include obtaining metastatic cancer tissue for research and validating biomarkers predicative for personalised therapeutic ...

1. Who is the specialist I should consult when I notice ascites? Ascites is treated by a gastroenterologist who will examine the patient first, and may then redirect the patient to another specialist ...

Sterile ascites after ventriculoperitoneal shunting is rare and usually of unknown cause. 1 We describe a patient in whom an inflammatory reaction to silicone tubing used in the creation of a shunt ...

FRANKLIN LAKES, N.J., June 23, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from ...

Our laboratory has refined the technique for isolating primary cultures of normal human ovarian surface epithelial (OSE) cells by combining two different protocols involving the enzymatic and ...

Fatty liver disease is sometimes called “silent liver disease” because of the few signs it shows until it has progressed. According to the NHS, one in three may be living with the early signs of fatty ...

Pharmanovia, a global pharmaceutical company that commercialises novel speciality medicines as well as trusted established medicines, has today announced the launch of catumaxomab in Germany, making ...